SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Core Scientific, Inc. (CORZ) has a negative trailing P/E of -19.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 281.3 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -5.06%, forward earnings yield 0.36%. PEG 2.19.
Criteria proven by this page:
- VALUE (90/100, Pass) — analyst target implies upside (+40.3%).
- Forward P/E 281.3 — analysts expect a return to profitability with estimated EPS of $0.07 for FY2026.
- PEG Ratio 2.19 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield -5.06% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.36% as earnings recover.
- Analyst consensus target $26.20 (+40.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 39/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CORZ
Valuation Multiples
P/E (TTM)-19.8
Forward P/E281.3
PEG Ratio2.19
Forward PEG2.19
P/B Ratio-5.93
P/S Ratio17.64
EV/EBITDA87.7
Per Share Data
EPS (TTM)$-0.90
Forward EPS (Est.)$0.07
Book Value / Share$-3.01
Revenue / Share$1.00
FCF / Share$-1.44
Yields & Fair Value
Earnings Yield-5.06%
Forward Earnings Yield0.36%
Dividend Yield0.00%
SharesGrow IV$688.77 (+3587.2%)
Analyst Target$26.20 (+40.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-109.6 |
0.00 |
9.62 |
21.95 |
- |
| 2020 |
-107.1 |
1.36 |
9.77 |
21.66 |
- |
| 2021 |
15.1 |
-0.03 |
0.53 |
1.31 |
- |
| 2022 |
-0.5 |
0.00 |
-2.86 |
1.83 |
- |
| 2023 |
-5.3 |
0.06 |
-2.19 |
2.60 |
- |
| 2024 |
-2.7 |
0.00 |
-4.38 |
7.04 |
- |
| 2025 |
-16.0 |
0.19 |
-4.81 |
14.52 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.12 |
$59.52M |
$-11.92M |
-20% |
| 2020 |
$0.00 |
$60.32M |
$-10.4K |
-0% |
| 2021 |
$0.20 |
$544.48M |
$47.31M |
8.7% |
| 2022 |
$-6.30 |
$640.31M |
$-2.15B |
-335.2% |
| 2023 |
$-0.65 |
$502.4M |
$-246.49M |
-49.1% |
| 2024 |
$-5.14 |
$510.67M |
$-1.32B |
-257.5% |
| 2025 |
$-0.88 |
$319.02M |
$-288.62M |
-90.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.07 |
$-0.36 – $0.33 |
$657.95M |
$512.25M – $923.58M |
7 |
| 2027 |
$0.40 |
$-3.77 – $5.14 |
$1.04B |
$802.64M – $1.32B |
5 |
| 2028 |
$0.89 |
$0.17 – $1.83 |
$1.39B |
$1.38B – $1.41B |
3 |
| 2029 |
$2.08 |
$1.04 – $2.96 |
$2.27B |
$1.4B – $3.01B |
1 |
| 2030 |
$1.80 |
$0.90 – $2.56 |
$2.72B |
$1.68B – $3.61B |
1 |
